US$ 26.45
breast cancer and semaglutide is associated with improved survival, lower metastatic burden, a dose–survival relationship unco Semaglutide decelerates the growth and
Description
Recently, a new class of drugs, based on GLP-1, are revolutionizing medicine and the treatment of patients with diabetes, obesity, and other disorders associated with obesity.

Propensity score fine stratification weighted Cox proportional hazards models were fitted to estimate hazard ratios and 95% confidence intervals (CIs) to estimate the average treatment effect among the treated patients

Generally, GLP-1 medications are considered for adults whose body mass index and medical history meet established clinical criteria

At Em, your care is medically guided, thoughtfully paced, and supported by a real care team throughout your journey